Bank Of New York Mellon Corp Novartis Ag Transaction History

Bank Of New York Mellon Corp

$538 Trillion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$75.55 - $92.52 $52.1 Million - $63.9 Million	690,215 New	690,215 $62.6 Million
Q3 2022 Nov 14, 2022	SELL	$74.61 - $87.26 $7.33 Million - $8.57 Million	-98,241 Reduced 12.85%	666,443 $50.7 Million
Q2 2022 Aug 15, 2022	SELL	$80.52 - $93.75 $894,174 - $1.04 Million	-11,105 Reduced 1.43%	764,684 $64.6 Million
Q1 2022 May 11, 2022	BUY	$80.11 - $90.62 $2.83 Million - $3.21 Million	35,370 Added 4.78%	775,789 $68.1 Million
Q4 2021 Feb 11, 2022	BUY	$79.7 - $88.13 $4.09 Million - $4.53 Million	51,360 Added 7.45%	740,419 $64.8 Million
Q3 2021 Nov 12, 2021	BUY	$81.78 - $95.14 $3.5 Million - $4.07 Million	42,795 Added 6.62%	689,059 $56.4 Million
Q2 2021 Aug 11, 2021	BUY	$85.24 - $94.15 $1.93 Million - $2.13 Million	22,588 Added 3.62%	646,264 $59 Million
Q1 2021 May 13, 2021	BUY	$83.5 - $98.47 $672,509 - $793,077	8,054 Added 1.31%	623,676 $53.3 Million
Q4 2020 Feb 09, 2021	SELL	$78.07 - $94.43 $1.32 Million - $1.6 Million	-16,924 Reduced 2.68%	615,622 $58.1 Million
Q3 2020 Nov 12, 2020	SELL	$82.14 - $91.0 $1.28 Million - $1.41 Million	-15,536 Reduced 2.4%	632,546 $55 Million
Q2 2020 Aug 12, 2020	SELL	$80.93 - $91.1 $6.42 Million - $7.23 Million	-79,366 Reduced 10.91%	648,082 $56.6 Million
Q1 2020 May 06, 2020	SELL	$70.67 - $99.01 $2.38 Million - $3.33 Million	-33,671 Reduced 4.42%	727,448 $60 Million
Q4 2019 Feb 14, 2020	BUY	$84.35 - $95.37 $11.3 Million - $12.8 Million	134,144 Added 21.4%	761,119 $72.1 Million
Q3 2019 Nov 07, 2019	BUY	$85.54 - $94.26 $1.72 Million - $1.89 Million	20,101 Added 3.31%	626,975 $54.5 Million
Q2 2019 Aug 12, 2019	BUY	$75.4 - $92.8 $329,498 - $405,536	4,370 Added 0.73%	606,874 $55.4 Million
Q1 2019 May 14, 2019	SELL	$75.32 - $86.15 $2.89 Million - $3.3 Million	-38,311 Reduced 5.98%	602,504 $57.9 Million
Q4 2018 Feb 11, 2019	BUY	$73.66 - $82.02 $369,625 - $411,576	5,018 Added 0.79%	640,815 $55 Million
Q3 2018 Nov 09, 2018	BUY	$66.94 - $77.43 $35.8 Million - $41.4 Million	534,268 Added 526.22%	635,797 $0
Q2 2018 Aug 24, 2018	SELL	$64.91 - $73.36 $31.4 Million - $35.4 Million	-483,179 Reduced 82.64%	101,529 $7.67 Million
Q2 2018 Aug 06, 2018	SELL	$64.91 - $73.36 $27 Million - $30.5 Million	-416,371 Reduced 41.59%	584,708 $44.2 Million
Q1 2018 May 15, 2018	SELL	$70.39 - $84.15 $2.89 Million - $3.45 Million	-41,001 Reduced 3.93%	1,001,079 $80.9 Million
Q4 2017 Feb 09, 2018	BUY	$72.33 - $77.64 $75.4 Million - $80.9 Million	1,042,080	1,042,080 $87.5 Million

Others Institutions Holding NVS

# of Institutions

1,437

Shares Held

131M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $212B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account